4.6 Article

PDZ-binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway

Journal

MOLECULAR CARCINOGENESIS
Volume 62, Issue 5, Pages 716-726

Publisher

WILEY
DOI: 10.1002/mc.23519

Keywords

everolimus; mTOR; pancreatic neuroendocrine neoplasms; PDZ-binding kinase; proliferation

Ask authors/readers for more resources

This study found that PBK is significantly upregulated in pNEN tissues and is a poor prognostic factor for pNEN patients. PBK promotes the proliferation of pNEN cells by activating the AKT/mTOR pathway. Inhibition of PBK combined with everolimus treatment enhances the antitumour effects on pNEN by inhibiting the AKT/mTOR pathway and inducing cell cycle arrest.
The therapeutic effects of existing drug regimens against pancreatic neuroendocrine neoplasms (pNENs) remain limited, and identifying ideal therapeutic targets is warranted. PDZ binding kinase (PBK) may play an oncogenic role in most solid tumors. However, its function in pNEN remains unclear. In this study, pNEN samples and International Cancer Genome Consortium data were used to determine the clinical significance of PBK. Cell counting and CCK8 assays were used to assess cell proliferation. Flow cytometry was used to assess drug-induced apoptosis and cell cycle arrest. An in vivo PBK-targeting experiment was performed in mice bearing pNENs. Western blotting, quantitative PCR, and immunohistochemistry were performed to assess the molecular mechanisms. PBK was significantly upregulated in pNEN tissues compared with paracancerous tissues. Additionally, PBK was a poor prognostic factor for pNEN patients. PBK was found to promote the proliferation of pNEN cells by activating the AKT/mTOR pathway. Furthermore, PBK inhibition combined with everolimus treatment had enhanced antitumour effects on pNEN via inhibiting AKT/mTOR pathway and inducing G0/G1 phase cell cycle arrest. This study highlights that PBK plays an oncogenic role in and is a promising therapeutic target for pNEN.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available